Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Negative clonal selection in tumor evolution.

Robert A Beckman1, Lawrence A Loeb

  • 1Dept. of Clinical Research and Development, Hematology/Oncology, Centocor, Malvern, PA 19355-1307, USA. eniac1@snip.net

Genetics
|September 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.

Stem cells translational medicine·2026
Same author

Probability Distribution for Rare Neutral Mutations in Cancers and Application to Dynamic Precision Medicine of Cancer.

bioRxiv : the preprint server for biology·2025
Same author

Insights on Clinical Development of Cell and Gene Therapy for Rare Diseases-by DahShu Innovative Design Scientific Working Group (IDSWG).

Therapeutic innovation & regulatory science·2025
Same author

A Proof-of-Concept Clinical Trial Design for Evolutionary Guided Precision Medicine for Cancer.

medRxiv : the preprint server for health sciences·2025
Same author

Personalized cancer treatment strategies incorporating irreversible and reversible drug resistance mechanisms.

NPJ systems biology and applications·2025
Same author

Integrating Sustainability Pillars Into Trial Design Decision-Making: Results of an International Survey.

Clinical and translational science·2025
Same journal

Inherited long telomeres induce a genome-wide transcriptional response in budding yeast.

Genetics·2026
Same journal

Adaptive Dynamics of Quantitative Traits in a Steadily Changing Environment.

Genetics·2026
Same journal

Functional Landscape of Zebrafish Gonadotropins and Receptors: A Comprehensive Genetic Analysis.

Genetics·2026
Same journal

Synergistic actions of Nup43 and Myosin VI drive actin cone assembly during Drosophila spermiogenesis.

Genetics·2026
Same journal

Identification of two Cryptococcus neoformans heme transporters involved in Fhb1-mediated nitrosative stress protection in a fission yeast model.

Genetics·2026
Same journal

Analysis of a hypomorphic mei-P26 mutation reveals coordination between developmental programming of germ cells and meiotic chromosome dynamics.

Genetics·2026
See all related articles

Mutator mutations accelerate cancer development but also increase harmful mutations. Mathematical analysis suggests negative selection against these cancer-promoting mutations is unlikely, especially with dominant reduced-fitness genes.

Area of Science:

  • Oncology
  • Genetics
  • Mathematical Biology

Background:

  • Cancer development involves accumulating mutations and selecting malignant cells.
  • Mutator mutations accelerate oncogenic mutation acquisition but also reduce cell fitness.
  • Reduced-fitness mutations can lead to negative clonal selection against mutator clones.

Purpose of the Study:

  • To mathematically analyze negative clonal selection against mutator clones.
  • To define the relative importance of dominant versus recessive reduced-fitness mutations.
  • To determine factors influencing the predominance of mutator mutations in clinical cancers.

Main Methods:

  • Direct mathematical analysis of negative clonal selection.
  • Quantitative definition of dominant and recessive reduced-fitness mutations.

Related Experiment Videos

  • Modeling the impact of genome tolerance to reduced-fitness mutations.

    • Main Results:

    • Negative clonal selection against mutator clones is unlikely to be significant under realistic conditions.
    • The relative importance of dominant and recessive reduced-fitness mutations was quantitatively defined.
    • The predominance of mutator mutations depends on genome tolerance and dominant reduced-fitness loci.

    Conclusions:

    • Negative selection against cancer-promoting mutator mutations is generally weak.
    • Dominant reduced-fitness mutations play a crucial role in limiting mutator clone expansion.
    • Cancer genome evolution is influenced by the balance between mutation acceleration and fitness reduction.